nodes	percent_of_prediction	percent_of_DWPC	metapath
Pseudoephedrine—TNF—osteoarthritis	0.787	1	CbGaD
Pseudoephedrine—IL2—synovial fluid—osteoarthritis	0.0463	0.903	CbGeAlD
Pseudoephedrine—NFATC1—tendon—osteoarthritis	0.00376	0.0735	CbGeAlD
Pseudoephedrine—MAOA—tendon—osteoarthritis	0.000676	0.0132	CbGeAlD
Pseudoephedrine—ADRA2A—tendon—osteoarthritis	0.000518	0.0101	CbGeAlD
Pseudoephedrine—IL2—Immune System—CTSK—osteoarthritis	0.0002	0.00123	CbGpPWpGaD
Pseudoephedrine—TNF—IL23-mediated signaling events—IL6—osteoarthritis	0.000195	0.00121	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—COL9A2—osteoarthritis	0.000195	0.0012	CbGpPWpGaD
Pseudoephedrine—MAOA—SIDS Susceptibility Pathways—IL1A—osteoarthritis	0.000192	0.00119	CbGpPWpGaD
Pseudoephedrine—TNF—TGF-beta Receptor Signaling—TGFB1—osteoarthritis	0.000192	0.00118	CbGpPWpGaD
Pseudoephedrine—TNF—Adipogenesis—LEP—osteoarthritis	0.000191	0.00118	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—IL1A—osteoarthritis	0.000191	0.00118	CbGpPWpGaD
Pseudoephedrine—TNF—Allograft Rejection—CXCL8—osteoarthritis	0.00019	0.00117	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—COL9A1—osteoarthritis	0.000189	0.00117	CbGpPWpGaD
Pseudoephedrine—TNF—Cardiac Hypertrophic Response—TGFB1—osteoarthritis	0.000189	0.00117	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—CRP—osteoarthritis	0.000189	0.00117	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—IHH—osteoarthritis	0.000188	0.00116	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—HSPA5—osteoarthritis	0.000188	0.00116	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—COL9A2—osteoarthritis	0.000184	0.00114	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—IL1RN—osteoarthritis	0.000183	0.00113	CbGpPWpGaD
Pseudoephedrine—TNF—Alzheimers Disease—IL1B—osteoarthritis	0.000182	0.00112	CbGpPWpGaD
Pseudoephedrine—TNF—Allograft Rejection—IL1B—osteoarthritis	0.000182	0.00112	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—MMP1—osteoarthritis	0.000179	0.00111	CbGpPWpGaD
Pseudoephedrine—TNF—Selenium Micronutrient Network—PTGS2—osteoarthritis	0.000179	0.00111	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—COL9A1—osteoarthritis	0.000179	0.00111	CbGpPWpGaD
Pseudoephedrine—IL2—Cytokine Signaling in Immune system—IL1B—osteoarthritis	0.000178	0.0011	CbGpPWpGaD
Pseudoephedrine—NFATC1—Fc epsilon receptor (FCERI) signaling—IL6—osteoarthritis	0.000177	0.0011	CbGpPWpGaD
Pseudoephedrine—TNF—TWEAK Signaling Pathway—IL6—osteoarthritis	0.000176	0.00109	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—IHH—osteoarthritis	0.000175	0.00108	CbGpPWpGaD
Pseudoephedrine—TNF—Selenium Micronutrient Network—IL1B—osteoarthritis	0.000167	0.00103	CbGpPWpGaD
Pseudoephedrine—IL2—Platelet activation, signaling and aggregation—TGFB1—osteoarthritis	0.000167	0.00103	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—COL9A2—osteoarthritis	0.000165	0.00102	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—FN1—osteoarthritis	0.000164	0.00101	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—COL9A1—osteoarthritis	0.00016	0.000989	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—HSPA5—osteoarthritis	0.000159	0.000981	CbGpPWpGaD
Pseudoephedrine—TNF—Adipogenesis—IGF1—osteoarthritis	0.000158	0.000977	CbGpPWpGaD
Pseudoephedrine—SLC6A4—Circadian rythm related genes—LEP—osteoarthritis	0.000156	0.000966	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Biological oxidations—GSTO1—osteoarthritis	0.000156	0.000961	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—IL1RN—osteoarthritis	0.000154	0.000954	CbGpPWpGaD
Pseudoephedrine—TNF—Toll-like Receptor Signaling Pathway—CXCL8—osteoarthritis	0.000154	0.000954	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metapathway biotransformation—GSTO1—osteoarthritis	0.000153	0.000948	CbGpPWpGaD
Pseudoephedrine—TNF—Vitamin B12 Metabolism—IL6—osteoarthritis	0.000151	0.000933	CbGpPWpGaD
Pseudoephedrine—TNF—Toll-like Receptor Signaling Pathway—IL1B—osteoarthritis	0.000148	0.000915	CbGpPWpGaD
Pseudoephedrine—TNF—Transcriptional regulation of white adipocyte differentiation—TGFB1—osteoarthritis	0.000144	0.000891	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—IGF1—osteoarthritis	0.000143	0.000886	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—PTGS2—osteoarthritis	0.000142	0.000876	CbGpPWpGaD
Pseudoephedrine—TNF—Allograft Rejection—TGFB1—osteoarthritis	0.000141	0.000873	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—HSPA5—osteoarthritis	0.000139	0.000856	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—CXCL8—osteoarthritis	0.000137	0.000849	CbGpPWpGaD
Pseudoephedrine—TNF—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—osteoarthritis	0.000134	0.000831	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	0.000134	0.00083	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—TIMP1—osteoarthritis	0.000132	0.000815	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—IL1B—osteoarthritis	0.000132	0.000815	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—IL1A—osteoarthritis	0.000131	0.000812	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—MCF2L—osteoarthritis	0.000131	0.000812	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—BMP2—osteoarthritis	0.00013	0.000801	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—MMP3—osteoarthritis	0.000129	0.000795	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—MCF2L—osteoarthritis	0.000129	0.000794	CbGpPWpGaD
Pseudoephedrine—SLC6A4—SIDS Susceptibility Pathways—CXCL8—osteoarthritis	0.000127	0.000787	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—MMP9—osteoarthritis	0.000124	0.000768	CbGpPWpGaD
Pseudoephedrine—TNF—Folate Metabolism—IL6—osteoarthritis	0.000123	0.000759	CbGpPWpGaD
Pseudoephedrine—SLC6A4—SIDS Susceptibility Pathways—IL1B—osteoarthritis	0.000122	0.000754	CbGpPWpGaD
Pseudoephedrine—TNF—Regulation of toll-like receptor signaling pathway—CXCL8—osteoarthritis	0.000121	0.000745	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—IHH—osteoarthritis	0.000119	0.000737	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—MCF2L—osteoarthritis	0.000119	0.000737	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—MCF2L—osteoarthritis	0.000117	0.000721	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—IHH—osteoarthritis	0.000117	0.000721	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	0.000116	0.000718	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—SMAD3—osteoarthritis	0.000116	0.000718	CbGpPWpGaD
Pseudoephedrine—TNF—Regulation of toll-like receptor signaling pathway—IL1B—osteoarthritis	0.000116	0.000715	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—osteoarthritis	0.000113	0.000698	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—IL1A—osteoarthritis	0.000111	0.000687	CbGpPWpGaD
Pseudoephedrine—TNF—SIDS Susceptibility Pathways—CXCL8—osteoarthritis	0.00011	0.000679	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—CRP—osteoarthritis	0.00011	0.000679	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—BMP2—osteoarthritis	0.00011	0.000678	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—FMOD—osteoarthritis	0.000106	0.000657	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—MCF2L—osteoarthritis	0.000106	0.000657	CbGpPWpGaD
Pseudoephedrine—TNF—SIDS Susceptibility Pathways—IL1B—osteoarthritis	0.000105	0.000652	CbGpPWpGaD
Pseudoephedrine—MAOA—SIDS Susceptibility Pathways—CXCL8—osteoarthritis	0.000104	0.000645	CbGpPWpGaD
Pseudoephedrine—IL2—Cytokine Signaling in Immune system—IL6—osteoarthritis	0.000104	0.000642	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—TGFB1—osteoarthritis	0.000102	0.000633	CbGpPWpGaD
Pseudoephedrine—MAOA—SIDS Susceptibility Pathways—IL1B—osteoarthritis	0.0001	0.000618	CbGpPWpGaD
Pseudoephedrine—SLC6A4—NRF2 pathway—TGFB1—osteoarthritis	0.0001	0.000618	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—IL1B—osteoarthritis	9.94e-05	0.000614	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—MCF2L—osteoarthritis	9.88e-05	0.00061	CbGpPWpGaD
Pseudoephedrine—TNF—Selenium Micronutrient Network—IL6—osteoarthritis	9.76e-05	0.000603	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—IHH—osteoarthritis	9.65e-05	0.000596	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—MCF2L—osteoarthritis	9.65e-05	0.000596	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	9.64e-05	0.000596	CbGpPWpGaD
Pseudoephedrine—TNF—Adipogenesis—TGFB1—osteoarthritis	9.48e-05	0.000586	CbGpPWpGaD
Pseudoephedrine—TNF—TNF alpha Signaling Pathway—IL6—osteoarthritis	9.42e-05	0.000582	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—CRP—osteoarthritis	9.3e-05	0.000574	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—MMP3—osteoarthritis	8.99e-05	0.000555	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—MCF2L—osteoarthritis	8.97e-05	0.000554	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—IHH—osteoarthritis	8.97e-05	0.000554	CbGpPWpGaD
Pseudoephedrine—SLC6A4—SIDS Susceptibility Pathways—TNF—osteoarthritis	8.86e-05	0.000547	CbGpPWpGaD
Pseudoephedrine—TNF—Toll-like Receptor Signaling Pathway—IL6—osteoarthritis	8.68e-05	0.000536	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PTGES—osteoarthritis	8.67e-05	0.000536	CbGpPWpGaD
Pseudoephedrine—SLC6A2—NRF2 pathway—TGFB1—osteoarthritis	8.6e-05	0.000532	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—TGFB1—osteoarthritis	8.59e-05	0.000531	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—SMAD3—osteoarthritis	8.14e-05	0.000503	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—TGFB1—osteoarthritis	7.72e-05	0.000477	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—IL6—osteoarthritis	7.72e-05	0.000477	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—SMAD3—osteoarthritis	7.7e-05	0.000476	CbGpPWpGaD
Pseudoephedrine—SLC6A3—NRF2 pathway—TGFB1—osteoarthritis	7.62e-05	0.000471	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—MMP3—osteoarthritis	7.6e-05	0.00047	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—FN1—osteoarthritis	7.49e-05	0.000463	CbGpPWpGaD
Pseudoephedrine—IL2—GPCR downstream signaling—CXCL8—osteoarthritis	7.29e-05	0.00045	CbGpPWpGaD
Pseudoephedrine—MAOA—SIDS Susceptibility Pathways—TNF—osteoarthritis	7.26e-05	0.000449	CbGpPWpGaD
Pseudoephedrine—SLC6A4—SIDS Susceptibility Pathways—IL6—osteoarthritis	7.15e-05	0.000442	CbGpPWpGaD
Pseudoephedrine—TNF—Adipogenesis—IL6—osteoarthritis	7.15e-05	0.000442	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—HSPA5—osteoarthritis	7.14e-05	0.000441	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—FMOD—osteoarthritis	7.11e-05	0.000439	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MCF2L—osteoarthritis	7.05e-05	0.000435	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IHH—osteoarthritis	7.05e-05	0.000435	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	6.97e-05	0.000431	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—LEP—osteoarthritis	6.95e-05	0.00043	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IHH—osteoarthritis	6.89e-05	0.000426	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MCF2L—osteoarthritis	6.89e-05	0.000426	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—IL6—osteoarthritis	6.89e-05	0.000426	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—SMAD3—osteoarthritis	6.88e-05	0.000425	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—IL1B—osteoarthritis	6.86e-05	0.000424	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—PTGS2—osteoarthritis	6.8e-05	0.00042	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—TIMP1—osteoarthritis	6.8e-05	0.00042	CbGpPWpGaD
Pseudoephedrine—TNF—Regulation of toll-like receptor signaling pathway—IL6—osteoarthritis	6.77e-05	0.000419	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—ESR1—osteoarthritis	6.64e-05	0.00041	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—CXCL8—osteoarthritis	6.62e-05	0.000409	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—LEP—osteoarthritis	6.58e-05	0.000407	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—IGF1—osteoarthritis	6.56e-05	0.000405	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—FN1—osteoarthritis	6.56e-05	0.000405	CbGpPWpGaD
Pseudoephedrine—TNF—SIDS Susceptibility Pathways—IL6—osteoarthritis	6.18e-05	0.000382	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—GSTO1—osteoarthritis	6.11e-05	0.000378	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—BGN—osteoarthritis	5.92e-05	0.000366	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—LEP—osteoarthritis	5.88e-05	0.000363	CbGpPWpGaD
Pseudoephedrine—MAOA—SIDS Susceptibility Pathways—IL6—osteoarthritis	5.86e-05	0.000362	CbGpPWpGaD
Pseudoephedrine—SLC6A4—Circadian rythm related genes—IL6—osteoarthritis	5.84e-05	0.000361	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—IL1B—osteoarthritis	5.8e-05	0.000358	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PTGES—osteoarthritis	5.8e-05	0.000358	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—IGF1—osteoarthritis	5.75e-05	0.000355	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IHH—osteoarthritis	5.7e-05	0.000352	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MCF2L—osteoarthritis	5.7e-05	0.000352	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—ESR1—osteoarthritis	5.62e-05	0.000347	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—FN1—osteoarthritis	5.55e-05	0.000343	CbGpPWpGaD
Pseudoephedrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—osteoarthritis	5.31e-05	0.000328	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IHH—osteoarthritis	5.3e-05	0.000327	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MCF2L—osteoarthritis	5.3e-05	0.000327	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—MMP2—osteoarthritis	5.26e-05	0.000325	CbGpPWpGaD
Pseudoephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—osteoarthritis	5.2e-05	0.000321	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—COL9A2—osteoarthritis	5.17e-05	0.00032	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—COL9A2—osteoarthritis	5.06e-05	0.000313	CbGpPWpGaD
Pseudoephedrine—ADRA2A—G alpha (i) signalling events—CXCL8—osteoarthritis	5.02e-05	0.00031	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—COL9A1—osteoarthritis	5.02e-05	0.00031	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—TGFB1—osteoarthritis	4.92e-05	0.000304	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—COL9A1—osteoarthritis	4.91e-05	0.000303	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—IGF1—osteoarthritis	4.86e-05	0.0003	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—FMOD—osteoarthritis	4.63e-05	0.000286	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—CXCL8—osteoarthritis	4.62e-05	0.000285	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—osteoarthritis	4.3e-05	0.000266	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—MMP1—osteoarthritis	4.23e-05	0.000261	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—COL9A2—osteoarthritis	4.19e-05	0.000259	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—MMP9—osteoarthritis	4.18e-05	0.000258	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—GSTO1—osteoarthritis	4.08e-05	0.000252	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—COL9A1—osteoarthritis	4.06e-05	0.000251	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—CXCL8—osteoarthritis	4.05e-05	0.00025	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—MMP3—osteoarthritis	4.04e-05	0.00025	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—IL6—osteoarthritis	4.01e-05	0.000248	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—osteoarthritis	3.99e-05	0.000247	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—CXCL8—osteoarthritis	3.96e-05	0.000244	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—MMP9—osteoarthritis	3.95e-05	0.000244	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—BGN—osteoarthritis	3.95e-05	0.000244	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—MMP3—osteoarthritis	3.95e-05	0.000244	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—osteoarthritis	3.93e-05	0.000243	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—CXCL8—osteoarthritis	3.91e-05	0.000241	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—COL9A2—osteoarthritis	3.89e-05	0.00024	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—FN1—osteoarthritis	3.86e-05	0.000238	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PTGES—osteoarthritis	3.78e-05	0.000233	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—COL9A1—osteoarthritis	3.78e-05	0.000233	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—IL6—osteoarthritis	3.72e-05	0.00023	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—IL6—osteoarthritis	3.71e-05	0.000229	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—MMP9—osteoarthritis	3.54e-05	0.000218	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—TGFB1—osteoarthritis	3.44e-05	0.000213	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—BMP2—osteoarthritis	3.44e-05	0.000213	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—IL6—osteoarthritis	3.4e-05	0.00021	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—IGF1—osteoarthritis	3.38e-05	0.000209	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—BMP2—osteoarthritis	3.37e-05	0.000208	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—CXCL8—osteoarthritis	3.27e-05	0.000202	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—MMP3—osteoarthritis	3.27e-05	0.000202	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoarthritis	3.26e-05	0.000201	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—TGFB1—osteoarthritis	3.26e-05	0.000201	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—CXCL8—osteoarthritis	3.04e-05	0.000188	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—MMP3—osteoarthritis	3.04e-05	0.000188	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—TGFB1—osteoarthritis	2.91e-05	0.00018	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—BMP2—osteoarthritis	2.78e-05	0.000172	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GSTO1—osteoarthritis	2.66e-05	0.000164	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—IL6—osteoarthritis	2.6e-05	0.00016	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—BMP2—osteoarthritis	2.59e-05	0.00016	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—BGN—osteoarthritis	2.58e-05	0.000159	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—IL6—osteoarthritis	2.46e-05	0.000152	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MMP3—osteoarthritis	2.39e-05	0.000147	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MMP3—osteoarthritis	2.33e-05	0.000144	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—CXCL8—osteoarthritis	2.29e-05	0.000141	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—CXCL8—osteoarthritis	2.24e-05	0.000138	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—IL6—osteoarthritis	2.2e-05	0.000136	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—SMAD3—osteoarthritis	2.16e-05	0.000133	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—SMAD3—osteoarthritis	2.11e-05	0.00013	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—CXCL8—osteoarthritis	2.08e-05	0.000128	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—CXCL8—osteoarthritis	2.03e-05	0.000125	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—TGFB1—osteoarthritis	2.03e-05	0.000125	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MMP3—osteoarthritis	1.93e-05	0.000119	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—CXCL8—osteoarthritis	1.85e-05	0.000114	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—LEP—osteoarthritis	1.85e-05	0.000114	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—LEP—osteoarthritis	1.81e-05	0.000112	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MMP3—osteoarthritis	1.79e-05	0.000111	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—ESR1—osteoarthritis	1.76e-05	0.000109	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—SMAD3—osteoarthritis	1.75e-05	0.000108	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—FN1—osteoarthritis	1.74e-05	0.000108	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—ESR1—osteoarthritis	1.72e-05	0.000106	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—CXCL8—osteoarthritis	1.72e-05	0.000106	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—FN1—osteoarthritis	1.7e-05	0.000105	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PTGS2—osteoarthritis	1.7e-05	0.000105	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—CXCL8—osteoarthritis	1.68e-05	0.000104	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—SMAD3—osteoarthritis	1.62e-05	0.0001	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CXCL8—osteoarthritis	1.56e-05	9.64e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IGF1—osteoarthritis	1.52e-05	9.42e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—LEP—osteoarthritis	1.49e-05	9.23e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IGF1—osteoarthritis	1.49e-05	9.22e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—ESR1—osteoarthritis	1.43e-05	8.81e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—FN1—osteoarthritis	1.41e-05	8.7e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—LEP—osteoarthritis	1.39e-05	8.57e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—ESR1—osteoarthritis	1.32e-05	8.18e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—FN1—osteoarthritis	1.31e-05	8.08e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IGF1—osteoarthritis	1.23e-05	7.62e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CXCL8—osteoarthritis	1.23e-05	7.58e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CXCL8—osteoarthritis	1.2e-05	7.41e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—IL6—osteoarthritis	1.17e-05	7.2e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IGF1—osteoarthritis	1.15e-05	7.08e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—IL6—osteoarthritis	1.14e-05	7.05e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PTGS2—osteoarthritis	1.14e-05	7.02e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MMP9—osteoarthritis	1.11e-05	6.85e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MMP9—osteoarthritis	1.09e-05	6.7e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CXCL8—osteoarthritis	9.92e-06	6.13e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—IL6—osteoarthritis	9.44e-06	5.83e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CXCL8—osteoarthritis	9.22e-06	5.7e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TGFB1—osteoarthritis	9.14e-06	5.65e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MMP9—osteoarthritis	8.98e-06	5.54e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TGFB1—osteoarthritis	8.94e-06	5.53e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—IL6—osteoarthritis	8.77e-06	5.42e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MMP9—osteoarthritis	8.34e-06	5.15e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PTGS2—osteoarthritis	7.41e-06	4.58e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TGFB1—osteoarthritis	7.4e-06	4.57e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IL6—osteoarthritis	6.89e-06	4.26e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TGFB1—osteoarthritis	6.87e-06	4.25e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IL6—osteoarthritis	6.74e-06	4.16e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IL6—osteoarthritis	5.57e-06	3.44e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IL6—osteoarthritis	5.18e-06	3.2e-05	CbGpPWpGaD
